Selected publications
-
Taselisib (GDC-0032), a potent β-sparing small molecule inhibitor of PI3K, radiosensitizes head and neck squamous carcinomas containing activating PIK3CA alterations.
Clinical Cancer Research.
2016
Academic Article
GET IT
Times cited: 22 -
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.
BMC Cancer.
2014
Academic Article
GET IT
Times cited: 5 -
The Twist box domain is required for Twist1-induced prostate cancer metastasis.
Molecular Cancer Research.
2013
Academic Article
GET IT
Times cited: 36 -
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.
Journal of Clinical Oncology.
2009
Academic Article
GET IT
Times cited: 52